Skip to content

13F-HR filed by Blue Water Life Science Advisors, LP

Blue Water Life Science Advisors, LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 7 holding rows worth $148,155,168.

Accession
0001172661-23-003180
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 7 entries on the cover page, a total value of $148,155,168 stated on the cover page (in dollars after the unit check, H1), rows summing to $148,155,168 with VALUE read as dollars as filed, 13F file number 028-20810. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATERA INC COM632307104Stock881,436$42,890,676dollars as filed
AKOYA BIOSCIENCES INC COM00974H104Stock4,697,785$34,716,631dollars as filed
GUARDANT HEALTH INC COM40131M109Stock676,047$24,202,483dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock3,030,434$20,334,212dollars as filed
NANOSTRING TECHNOLOGIES INC63009R109COM2,726,891$11,043,909dollars as filed
MAXCYTE INC57777K106COM1,885,000$8,652,150dollars as filed
SONENDO INC835431107Common Stocks4,643,461$6,315,107dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-23-003180this filing2023-08-14acceptance time not in the bulk data set